NAD+ Glutathione: Biomarker Context and Clinical Decision-Making

Last reviewed: May 31, 2026

Last updated: May 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD+ (nicotinamide adenine dinucleotide) and glutathione are essential molecules that support cellular energy production and antioxidant defense. NAD+ levels naturally decline with age—declining approximately 50% between age 40 and 60—while glutathione serves as the body's primary intracellular antioxidant, protecting cells from oxidative stress and supporting detoxification pathways.

Interest in NAD+ and glutathione supplementation has grown among individuals seeking to optimize metabolic health and resilience. However, understanding whether these interventions align with your personal biochemistry requires context beyond general recommendations. PlexusDx supports precision-wellness conversations by integrating biomarker insights and genetic predisposition data, enabling providers to make more informed, individualized recommendations.

NAD+ and Glutathione: Cellular Roles and Metabolic Functions

NAD+ functions as a critical coenzyme in hundreds of enzymatic reactions, including energy metabolism (ATP production), DNA repair, and sirtuin activation—pathways associated with cellular longevity and stress resilience. Glutathione exists in reduced (GSH) and oxidized (GSSG) forms, directly neutralizing free radicals and supporting phase II detoxification of xenobiotics and metabolic byproducts.

Both molecules decline with age, chronic stress, poor nutrition, and certain disease states. This decline correlates with reduced energy capacity, impaired antioxidant defense, and slower cellular repair mechanisms. Understanding baseline NAD+ and glutathione status through biomarker assessment may help providers evaluate whether supplementation addresses an actual biochemical need versus general enhancement.

Biomarker Assessment and Individual Variation in NAD+ and Glutathione Status

Individual NAD+ and glutathione levels vary significantly based on genetics, age, metabolic health, physical activity, and nutrient intake. Some individuals possess genetic variants that affect NAD+ biosynthesis pathways or antioxidant enzyme expression, influencing baseline status and potential responsiveness to supplementation. Biomarker-guided assessment can reveal whether low levels truly exist and warrant intervention.

Factor Affecting Status	Clinical Relevance
Age and aging	NAD+ declines ~50% by age 60; cellular repair slows without intervention
Physical activity level	Exercise upregulates NAD+ biosynthesis and antioxidant enzyme expression
Nutrient intake (B vitamins, amino acids)	Precursors like NMN, NR, and cysteine affect NAD+ and glutathione synthesis
Genetic variation in metabolic pathways	SIRT genes, NAMPT, and antioxidant enzyme variants influence baseline status and response
Chronic stress and inflammation	Oxidative stress depletes glutathione; NAD+ consumption increases with chronic activation
Liver and kidney function	Organ health directly impacts NAD+ recycling and glutathione conjugation capacity

Clinical Evidence: What Research Shows About Supplementation

Research on NAD+ precursors (nicotinamide riboside, nicotinamide mononucleotide) shows modest improvements in mitochondrial function, exercise capacity, and metabolic markers in some populations. A 2021 randomized trial found NR supplementation improved muscle insulin sensitivity in prediabetic adults. However, effect sizes remain modest, and benefits vary widely between individuals.

Glutathione supplementation research is more limited due to poor oral bioavailability of free glutathione. N-acetylcysteine (NAC), a glutathione precursor, shows evidence for supporting respiratory and antioxidant health in specific populations. Direct intracellular glutathione elevation requires either precursor supplementation or lifestyle modifications (exercise, sleep, stress management) that stimulate endogenous synthesis.

Provider-Guided Decision-Making and Safety Considerations

Before considering NAD+ or glutathione supplementation, qualified providers should assess baseline biomarkers (NAD+ levels where accessible, oxidative stress markers like 8-OHdG, antioxidant enzyme activity), review medication interactions, and evaluate whether lifestyle factors (sleep, exercise, nutrient status) can be optimized first. Supplementation may be premature if foundational health gaps exist.

Safety is generally favorable in healthy individuals, but NAD+ precursors may interact with certain medications, and very high glutathione doses in some conditions warrant caution. Individuals with specific metabolic disorders, active infections, or those on immunosuppressive therapies should consult providers before starting these interventions. Genetic predispositions in detoxification pathways may also influence individual tolerance.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic and antioxidant pathways—including variants in SIRT genes, detoxification enzymes, and oxidative stress response mechanisms—that may help provide context for NAD+ and glutathione supplementation decisions. These genetic insights should be interpreted with a qualified healthcare provider as part of a broader assessment.

The genetic test identifies individual predispositions toward reduced NAD+ biosynthesis capacity, slower antioxidant enzyme expression, or higher oxidative stress sensitivity. However, genetic predispositions do not predict exact supplement response; they inform which individuals may benefit from biomarker measurement and targeted intervention. Environmental factors and lifestyle modifications often have equal or greater impact than genetics alone.

Understanding your genetic context alongside biomarker assessment can support a more personalized conversation with your provider about whether NAD+ or glutathione supplementation aligns with your individual biochemistry, health goals, and foundational wellness practices.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the difference between NAD+ and glutathione?

NAD+ is a coenzyme supporting energy metabolism and DNA repair; glutathione is an antioxidant neutralizing free radicals and supporting detoxification. Both decline with age and stress, but operate through distinct biochemical mechanisms requiring different assessment and supplementation approaches.

Can I test my current NAD+ and glutathione levels?

NAD+ and glutathione biomarkers are measurable through specialized blood and intracellular assays, though not all clinics offer them routinely. Your provider can order oxidative stress markers and antioxidant enzyme activity as proxy indicators. Functional or integrative practitioners often have greater familiarity with these assessments.

How does the PlexusDx Precision Peptide Genetic Test relate to NAD+ and glutathione supplementation?

The test reveals genetic predispositions in metabolic and antioxidant pathways that may inform whether you're at higher risk for NAD+ depletion or oxidative stress sensitivity. These insights support personalized conversations with your provider about whether supplementation addresses your individual biology.

Are NAD+ and glutathione supplements safe for everyone?

Generally safe in healthy individuals, but interactions with certain medications, specific metabolic conditions, and immune status warrant provider review. Individuals with mitochondrial disorders, active infections, or on immunosuppressants should seek guidance before starting supplementation.

Should I supplement with NAD+ and glutathione if I feel healthy?

Feeling healthy does not confirm optimal NAD+ or glutathione status. Provider-guided biomarker assessment and evaluation of lifestyle factors (sleep, exercise, nutrient intake, stress) should precede supplementation. Many individuals achieve meaningful improvements through foundational wellness practices alone.

Related Reading

• Ozempic What Is It
• Can I Increase Nad Based On My Genetics
• Sirt1 Pathway Genetics Nad Cellular Repair
• What Genes Affect Glutathione Production

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.